FrancophonIA/ELRC3.0 huggingface dataset:
English: <This medicine has been authorised under “exceptional circumstances”.
Croatian: <Ovaj lijek je odobren u „iznimnim okolnostima”.
English: <No special requirements <for disposal>.>
Croatian: <Nema posebnih zahtjeva <za zbrinjavanje>.>
English: <Use in the paediatric population>
Croatian: <Primjena u pedijatrijskoj populaciji>
English: <Biotransformation>
Croatian: <Biotransformacija>
English: NN: {number} [national reimbursement number or other national number identifying the medicinal product]>
Croatian: NN: {broj} [nacionalni broj s liste lijekova ili drugi nacionalni broj za identifikaciju lijeka]>
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
Croatian: PODACI KOJE mora najmanje sadržavati blister ILI STRIP
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT
Croatian: 5. SADRŽAJ po težini, volumenu ili DOZNOJ jedinici lijeka
English: {Name}
Croatian: {Naziv}
English: <This medicinal product is authorised in the Member States of the EEA under the following names:>
Croatian: <Ovaj lijek je odobren u državama članicama Europskog gospodarskog prostora (EGP) pod sljedećim nazivima:>
English: <Not all pack sizes may be marketed.>
Croatian: <Na tržištu se ne moraju nalaziti sve veličine pakiranja.>
English: <No interaction studies have been performed.>
Croatian: <Nisu provedena ispitivanja interakcija.>
English: For MRP and DCP procedures: The actual details of the national reporting system (as listed within the Appendix V) of the concerned Member State(s) shall be displayed on the printed version and may also be displayed in the electronic national translation, published or not published.
Croatian: Za MRP i DCP postupke: Stvarni podaci o nacionalnom sustavu prijave nuspojava (kao što je navedeno u Dodatku V) države(a) sudionice(a) bit će navedeni na tiskanoj verziji, a mogu također biti navedeni u elektroničkoj verziji nacionalnog prijevoda, bilo da je objavljena ili ne.
English: X with <food> <and> <,> <drink> <and> <alcohol>
Croatian: X s <hranom> <i> <,> <pićem> <i> <alkoholom>
English: <Do not use this medicine if you notice {description of the visible signs of deterioration}.>
Croatian: <Ovaj lijek se ne smije upotrijebiti ako primijetite {opis vidljivih znakova odstupanja u kakvoći}.>
English: <Pharmacokinetic/pharmacodynamic relationship(s)>
Croatian: <Farmakokinetički/farmakodinamički odnos(i)>
English: No reference to the Appendix V should be included in the printed materials.
Croatian: Poveznica na Dodatak V se ne navodi u tiskanim materijalima.
English: - <if you are allergic to {active substance(s)} or any of the other ingredients of this medicine (listed in section 6).>
Croatian: <ako ste alergični na{djelatnu(e) tvar(i)} ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.).>
English: INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS>
Croatian: <12. UPUTE ZA PRIPREMU RADIOFARMACEUTIKA>
English: <Precautions to be taken before handling or administering the medicinal product>
Croatian: <Mjere opreza koje je potrebno poduzeti prije rukovanja ili primjene lijeka.>
English: <If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your <doctor> <or> <pharmacist> for advice before taking this medicine.>
Croatian: <Ako ste trudni ili dojite, mislite da biste mogli biti trudni ili planirate imati dijete, obratite se svom <liječniku> <ili> <ljekarniku> za savjet prije nego uzmete ovaj lijek.>
English: <The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.>
Croatian: <Urez služi samo kako bi se olakšalo lomljenje tablete radi lakšeg gutanja, a ne da bi se podijelila na jednake doze.>
English: Package leaflet: Information for the <patient> <user>
Croatian: Uputa o lijeku: Informacije za <bolesnika>
English: Children <and adolescents>
Croatian: Djeca <i adolescenti>
English: <Adverse reactions not observed in clinical studies, but seen in animals at exposure levels similar to clinical exposure levels and with possible relevance to clinical use were as follows:>
Croatian: <Nuspojave koje nisu zabilježene u kliničkim ispitivanjima, ali su zapažene u životinja pri razinama izloženosti sličnima razinama izloženosti u ljudi i s mogućom važnošću za kliničku primjenu, bile su sljedeće:>
English: For referral procedures: Please refer to the guidance in the annotated QRD template for centralised procedures.]
Croatian: Za arbitražne postupke: Vidjeti uputu u QRD predlošku za centralizirane postupke s pojašnjenjima.]
English: <{DD/MM/YYYY}>
Croatian: <{DD/MM/GGGG}>
English: <Justification for not including Braille accepted.>
Croatian: <Prihvaćeno obrazloženje za nenavođenje Brailleovog pisma.>
English: <Date of first authorisation: {DD month YYYY}>
Croatian: <Datum prvog odobrenja: {DD mjesec GGGG}>
English: <{DD month YYYY}>
Croatian: <{DD mjesec GGGG}>
English: This means that <due to the rarity of the disease> <for scientific reasons> <for ethical reasons> it has not been possible to obtain complete information on this medicinal product.
Croatian: To znači da <s obzirom na malu učestalost bolesti> <zbog znanstvenih razloga> <zbog etičkih razloga> nije bilo moguće doći do potpunih informacija o ovom lijeku.
English: <Excipient(s) with known effect>
Croatian: <Pomoćna(e) tvar(i) s poznatim učinkom>
English: <{Invented name} has <no or negligible influence> <minor influence> <moderate influence> <major influence> on the ability to drive and use machines.>
Croatian: <{Novoizumljeno ime} <ne utječe ili zanemarivo utječe> <malo utječe> <umjereno utječe> <značajno utječe> na sposobnost upravljanja vozilima i rada sa strojevima.>
English: < PC: {number} [product code]
Croatian: < PC: {broj} [oznaka lijeka]
English: You must talk to a doctor if you do not feel better or if you feel worse <after {number of} days.>>
Croatian: Obavezno se obratite liječniku ako se ne osjećate bolje ili ako se osjećate lošije <nakon {broj} dana.>>
English: PARTICULARS TO APPEAR ON <THE OUTER PACKAGING> <AND> <THE IMMEDIATE PACKAGING>
Croatian: PODACI KOJI SE MORAJU NALAZITI NA < VANJSKOM PAKIRANJU> <I> <UNUTARNJEM PAKIRANJU>
English: <Any unused medicinal product or waste material should be disposed of in accordance with local requirements.>
Croatian: <Neiskorišteni lijek ili otpadni materijal valja zbrinuti sukladno nacionalnim propisima.>
English: Pregnancy <and> <,> breast-feeding <and fertility>
Croatian: Trudnoća <i> <,> dojenje <i plodnost>
English: <The score line is only there to help you break the tablet if you have difficulty swallowing it whole.>
Croatian: <Urez služi samo da Vam pomogne prelomiti tabletu ako je ne možete progutati cijelu.>
English: {name MS/Agency} will review any new information on this medicine every year and this leaflet will be updated as necessary.>
Croatian: {naziv nadležnog tijela države članice} će svake godine procjenjivati nove informacije o ovom lijeku te će se ova uputa ažurirati prema potrebi.>
English: <You must talk to a doctor if you do not feel better or if you feel worse <after {number of} days>.>
Croatian: <Obavezno se obratite liječniku ako se ne osjećate bolje ili ako se osjećate lošije <nakon {broj} dana>.>
English: <Pharmacodynamic effects>
Croatian: <Farmakodinamički učinci>
English: Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in HYPERLINK "http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc" Appendix V.*
Croatian: Od zdravstvenih radnika traži se da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava; navedenog u HYPERLINK "http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc" Dodatku V.*
English: <If you <take> <use> more X than you should>
Croatian: <Ako <uzmete> <primijenite> više X nego što ste trebali>
English: <Tell your <doctor> <or> <pharmacist> if you are <taking> <using>, have recently <taken> <used> or might <take> <use> any other medicines.>
Croatian: <Obavijestite svog <liječnika> <ili> <ljekarnika> ako <uzimate> <primjenjujete>, nedavno ste <uzeli> <primijenili> ili biste mogli <uzeti> <primijeniti> bilo koje druge lijekove.>
English: <This medicine is subject to additional monitoring.
Croatian: <Ovaj je lijek pod dodatnim praćenjem.
English: <The score line is not intended for breaking the tablet.>
Croatian: <Urez nije namijenjen za lomljenje tablete.>
English: <Date of latest renewal: {DD month YYYY}>
Croatian: <Datum posljednje obnove odobrenja: {DD mjesec GGGG}>
English: <Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use.>
Croatian: <U nekliničkim ispitivanjima zapaženi su učinci samo pri izloženosti dozama koje su znatno veće od maksimalno dozvoljenih u ljudi, što ukazuje na njihov mali značaj za kliničku primjenu.>
English: <{X} is indicated in <adults> <neonates> <infants> <children> <adolescents> <aged {x to y}> <years> <months>.>
Croatian: <{X} je indiciran(a) u <odraslih> <novorođenčadi> <dojenčadi> <djece> <adolescenata> <u dobi {od x do y}> <godina> <mjeseci>.>
English: <Distribution>
Croatian: <Distribucija>
English: Do not use this medicine after the expiry date which is stated on the <label> <carton> <bottle> <...> <after {abbreviation used for expiry date}.> <The expiry date refers to the last day of that month.>
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na <naljepnici> <kutiji> <boci> <…> <iza oznake {kratica upotrijebljena za rok valjanosti}.>
English: You can also report side effects directly via the national reporting system listed in HYPERLINK "http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"Appendix V.* By reporting side effects you can help provide more information on the safety of this medicine.
Croatian: Nuspojave možete prijaviti izravno putem nacionalnog sustava za prijavu nuspojava; navedenog u HYPERLINK "http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc" Dodatku V.* Prijavljivanjem nuspojava možete pridonijeti u procjeni sigurnosti ovog lijeka.
English: SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
Croatian: 10. posebne mjere za ZBRINJAVANJE neiskorištenog lijeka ili OTPADNIH MATERIJALA KOJI POTJEČU
English: See section 4.8 for how to report adverse reactions.> [For medicinal products subject to additional monitoring ONLY]
Croatian: Za postupak prijavljivanja nuspojava vidjeti dio 4.8.> [SAMO za lijekove pod dodatnim praćenjem]
English: <Elimination>
Croatian: <Eliminacija>
English: <Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1 <or {name of the residue(s)}>.>
Croatian: <Preosjetljivost na djelatnu(e) tvar(i) ili neku od pomoćnih tvari navedenih u dijelu 6.1 <ili {naziv ostatne(ih) tvari}>.>
English: <X contains {name the excipient(s)}>
Croatian: <X sadrži {naziv pomoćne(ih) tvari}>
English: <Detailed information on this medicine is available on the website of {name of MS Agency (link)}>
Croatian: <Detaljnije informacije o ovom lijeku dostupne su na internetskoj stranici {naziv nadležnog tijela države članice (poveznica)}>
English: The other <ingredient(s)> <(excipient(s))> is (are)...
Croatian: Drugi(a)(e) <sastojak(ci)> <(pomoćna(e) tvar(i))> je (su)...
English: <Mechanism of action>
Croatian: <Mehanizam djelovanja>
English: Talk to your doctor <or> <,> <pharmacist> <or nurse> before <taking> <using> X
Croatian: Obratite se svom liječniku <ili> <,> <ljekarniku> <ili medicinskoj sestri> prije nego <uzmete> <primijenite> X.
English: Do not <take> <use> X<:>
Croatian: Nemojte <uzimati> <primjenjivati> X<:>
English: <For the full list of excipients, see section 6.1.>
Croatian: <Za cjeloviti popis pomoćnih tvari vidjeti dio 6.1.>
English: <The European Medicines Agency has deferred the obligation to submit the results of studies with <{(Invented) Name}> [or for generics: <the reference medicinal product containing {name of the active substance(s)}>] in one or more subsets of the paediatric population in {condition, as per Paediatric Investigation Plan (PIP) decision, for the granted indication} (see section 4.2 for information on paediatric use).>
Croatian: <Europska agencija za lijekove odgodila je obvezu podnošenja rezultata ispitivanja lijeka <{(Novoizumljeno) ime}> [ili za generičke lijekove: <referentni lijek koji sadrži {ime djelatne(ih) tvari}>] u jednoj ili više podskupina pedijatrijske populacije u {uvjeti zadani po Planu istraživanja u pedijatrijskoj populaciji (PIP-u), za odobrenu indikaciju} (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).>
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Croatian: PODACI KOJE mora najmanje sadržavati MALO UNUTARNJE PAKIRANJE
English: <The European Medicines Agency has waived the obligation to submit the results of studies with <{(Invented) Name}> [or for generics: <the reference medicinal product containing {name of the active substance(s)}>] in all subsets of the paediatric population in {condition as per Paediatric Investigation Plan (PIP) decision, for the granted indication} (see section 4.2 for information on paediatric use).>
Croatian: <Europska agencija za lijekove izuzela je obvezu podnošenja rezultata ispitivanja lijeka <{(Novoizumljeno) ime}> [ili za generičke lijekove: <referentni lijek koji sadrži {ime djelatne(ih) tvari}>] u svim podskupinama pedijatrijske populacije u {uvjeti zadani po Planu istraživanja u pedijatrijskoj populaciji (PIP-u), za odobrenu indikaciju} (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).>
English: See the end of section 4 for how to report side effects.> [For medicinal products subject to additional monitoring ONLY]
Croatian: Za postupak prijavljivanja nuspojava, pogledajte dio 4.> [SAMO za lijekove pod dodatnim praćenjem]
English: <Always <take> <use> this medicine exactly as your doctor <or pharmacist> has told you.
Croatian: <Uvijek <uzmite> <primijenite> ovaj lijek točno onako kako Vam je rekao liječnik <ili ljekarnik>.
English: <For storage conditions after <reconstitution> <dilution> <first opening> of the medicinal product, see section 6.3>
Croatian: <razrjeđivanja> <prvog otvaranja> lijeka vidjeti u dijelu 6.3.>
English: <For instructions on <reconstitution> <dilution> of the medicinal product before administration, see section <6.6> <and> <12>.>
Croatian: <razrjeđivanju> lijeka prije primjene vidjeti dio <6.6> <i> <12>.>
English: <Additional side effects in children <and adolescents>>
Croatian: <Dodatne nuspojave u djece <i adolescenata>>
English: <ANNEX III> [For referral procedures]
Croatian: <PRILOG III.> [za arbitražne postupke]
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Croatian: 11. NAZIV i adresa nositelja odobrenja za stavljanje lijeka u promet
English: How to <take> <use> X
Croatian: Kako <uzimati> <primjenjivati> X
English: DOSIMETRY>
Croatian: <11. DOZIMETRIJA
English: <If you stop <taking> <using> X>
Croatian: <Ako prestanete <uzimati> <primjenjivati> X>
English: <Fertility>
Croatian: <Plodnost>
English: The active substance(s) is (are)…
Croatian: Djelatna(e) tvar(i) je (su)…
English: <Pregnancy>
Croatian: <Trudnoća>
English: Ask your pharmacist if you need more information or advice.
Croatian: Ako trebate dodatne informacije ili savjet, obratite se svom ljekarniku.
English: Nature and contents of container
Croatian: 6.5 Vrsta i sadržaj spremnika
English: Clinical particulars
Croatian: 4. KLINIČKI PODACI
English: Check with your <doctor> <or> <pharmacist> if you are not sure.>
Croatian: <ili> <ljekarnikom> ako niste sigurni.>
English: <[See Annex I - To be completed nationally]> [For referral procedures, as appropriate]
Croatian: - Ispunjava država članica]> [za arbitražne postupke, kako je prikladno]
English: <[To be completed nationally]> [For referral procedures]
Croatian: <[Ispunjava država članica]> [za arbitražne postupke]
English: <There is no relevant use of {X} <in the paediatric population> <in children aged {x to y} <years>, <months> [or any other relevant subsets, e.g. weight, pubertal age, gender] <for the indication of...>.>
Croatian: <Nema relevantne primjene {X} <u pedijatrijskoj populaciji> <u djece u dobi {od x do y} <godine(a)>, <mjeseci(a)> [ili u bilo kojoj drugoj bitnoj podskupini, npr. prema težini, pubertetu, spolu] <za indikaciju...>.>
English: <{X} is contraindicated in children aged {x to y} <years> <months> [or any other relevant subsets, e.g. weight, pubertal age, gender] <for the indication of...> (see section 4.3).>
Croatian: <{X} je kontraindiciran(a) u djece u dobi {od x do y} <godine(a)>, <mjeseci(a)> [ili u bilo kojoj drugoj bitnoj podskupini, npr. prema težini, pubertetu, spolu] <za indikaciju...> (vidjeti dio 4.3).>
English: <The <safety> <and> <efficacy> of {X} in children aged {x to y} <months> <years> [or any other relevant subsets, e.g. weight, pubertal age, gender] <has> <have> not <yet> been established.>
Croatian: <Sigurnost> <i> <djelotvornost> {X} u djece u dobi {od x do y} <mjeseci(a)> <godine(a)> [ili u bilo kojoj drugoj bitnoj podskupini, npr. prema težini, pubertetu, spolu] <nije> <nisu> <još> ustanovljena(e).>
English: SUMMARY OF PRODUCT CHARACTERISTICS,
Croatian: SAŽETAK OPISA SVOJSTAVA LIJEKA,
English: <{X} should not be used in children aged {x to y} <years> <months> [or any other relevant subsets, e.g. weight, pubertal age, gender] because of <safety> <efficacy> concern(s).>
Croatian: <{X} se ne smije primjenjivati u djece u dobi {od x do y} <godine(a)> <mjeseci(a)> [ili u bilo kojoj drugoj bitnoj podskupini, npr. prema težini, pubertetu, spolu] zbog razloga <sigurnosti> <djelotvornosti>.>
English: <If you forget to <take> <use> X>
Croatian: <Ako ste zaboravili <uzeti> <primijeniti> X>
English: Always <take> <use> this medicine exactly as described in this leaflet or as your <doctor> <,> <or> <pharmacist> <or nurse> <has> <have> told you.
Croatian: Uvijek <uzmite> <primijenite> ovaj lijek točno onako kako je opisano u ovoj uputi ili kako Vam je rekao <liječnik> <,> <ili> <ljekarnik> <ili medicinska sestra>.
English: <Always <take> <use> this medicine exactly as described in this leaflet or as your <doctor> <,> <or> <pharmacist> <or nurse> <has> <have> told you.
Croatian: <Uvijek <uzmite> <primijenite> ovaj lijek točno onako kako je opisano u ovoj uputi ili kako Vam je rekao <liječnik> <,> <ili> <ljekarnik> <ili medicinska sestra>.
English: Detailed information is available on the website of {name of MS/Agency}>
Croatian: Detaljnije informacije dostupne su na internetskoj stranici
English: <Use in children <and adolescents>>
Croatian: <Primjena u djece <i adolescenata>>
English: <{Name of the Member State}> <{Name of the medicinal product}>
Croatian: {Naziv države članice/nadležnog tijela}>
English: NAME OF THE MARKETING AUTHORISATION HOLDER
Croatian: NAZIV nositelja odobrenja za stavljanje lijeka u promet
English: If you have any further questions, ask your <doctor> <,> <or> <pharmacist> <or nurse>.
Croatian: Ako imate dodatnih pitanja, obratite se <liječniku> <,> <ili> <ljekarniku>
English: <Absorption>
Croatian: <Apsorpcija>
English: <If you have any further questions on the use of this medicine, ask your <doctor> <,> <or> <pharmacist>< or nurse>.>
Croatian: <U slučaju bilo kakvih pitanja u vezi s primjenom ovog lijeka, obratite se <liječniku> <,> <ili> <ljekarniku>
English: PHARMACEUTICAL form
Croatian: 3. FARMACEUTSKI
English: It may harm them, even if their signs of illness are the same as yours.>
Croatian: Može im naškoditi, čak i ako su njihovi znakovi bolesti jednaki Vašima.>
English: 6.6 Special precautions for disposal <and other handling>
Croatian: 6.6 Posebne mjere za zbrinjavanje
English: If you get any side effects, talk to your <doctor> <,> <or> <pharmacist> <or nurse>.
Croatian: Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti <liječnika> <,> <ili> <ljekarnika> <ili medicinsku sestru>.
English: Check with your <doctor> <or> <,> <pharmacist> <or nurse> if you are not sure.>
Croatian: Provjerite s liječnikom <ili> <,> <ljekarnikom>
English: {Route of administration}
Croatian: {Put primjene}
English: This may appear several days after birth.
Croatian: To se može pojaviti nekoliko dana nakon rođenja.
English: This must be for at least 30 days and to be decided by your doctor.
Croatian: To mora trajati najmanje 30 dana i o tome će odlučiti liječnik.
English: Local representative contact
Croatian: Kontakt lokalnog predstavnika
English: Sixmo with food, drink and alcohol
Croatian: Sixmo s hranom, pićem i alkoholom
English: • participation in a structured activity/job
Croatian: • sudjelovanje u strukturiranoj aktivnosti/posao
English: Patients over 65 years
Croatian: Bolesnici stariji od 65 godina
English: 747 70 Opava, Komarov CZECH REPUBLIC
Croatian: 747 70 Opava, Komarov ČEŠKA REPUBLIKA
English: • The patient should be able to lie on their back.
Croatian: • Bolesnik mora biti u mogućnosti ležati na leđima.
English: Important aspects to consider during treatment:
Croatian: Važni aspekti koje treba uzeti u obzir tijekom liječenja:
English: Do not attempt to remove the implants by yourself as this could be very dangerous.
Croatian: Nemojte sami pokušavati ukloniti implantate jer to može biti jako opasno.
English: 50018 Scandicci (Firenze), Italy
Croatian: 50018 Scandicci (Firenze), Italija
English: • complication after the procedure
Croatian: • komplikacija nakon postupka
English: The experience of a second treatment cycle is limited.
Croatian: Iskustvo s drugim ciklusom liječenja je ograničeno.
English: Risk of expulsion
Croatian: Rizik od izbacivanja
English: Therefore, dosages must be limited and this combination must be avoided in cases where there is a risk of misuse.
Croatian: Stoga doze moraju biti ograničene i ova se kombinacija mora izbjegavati u slučajevima gdje postoji rizik od pogrešne primjene.
English: • reopening of a closed wound
Croatian: • ponovno otvaranje zatvorene rane
English: • stability of living environment
Croatian: • stabilnost životnog okruženja
English: Please attend all of these necessary appointments.
Croatian: Otiđite na svaki od ovih potrebnih pregleda.
English: See “Driving and using machines”.
Croatian: Pogledajte „Upravljanje vozilima i strojevima“.
English: • Drowsiness may occur especially in the first week after insertion.
Croatian: • Omamljenost se može opojaviti osobito u prvom tjednu nakon ugradnje.
English: Scandicci ITALY
Croatian: Scandicci ITALIJA
English: Overdose symptoms include:
Croatian: Simptomi predoziranja uključuju:
English: • social support system
Croatian: • sustav društvene potpore
English: Treating doctor (name / contact information):
Croatian: Nadležni liječnik (ime i prezime/ kontakt podaci):
English: 1 single use applicator
Croatian: 1 aplikator za jednokratnu uporabu
English: In some cases, the dose delivered by the implants might be more than the one you need.
Croatian: U nekim slučajevima, doza isporučena iz implantata može biti viša od one koja Vam je potrebna.
English: Weeks 17 to 24
Croatian: 17. do 24. tjedna
English: Cardiac arrest or arrhythmias will require advanced life support techniques.
Croatian: Srčani arest ili aritmije zahtijevat će primjenu naprednih tehnika održavanja života.
English: • cold sweat, dry skin
Croatian: • hladan znoj, suha koža
English: What Sixmo is and what it is used for
Croatian: Što je Sixmo i za što se koristi
English: Avoid grapefruit juice to prevent possible side effects.
Croatian: Izbjegavajte sok od grejpfruta radi sprječavanja mogućih nuspojava.
English: The syndrome is generally delayed for several hours to several days after birth.
Croatian: Sindrom općenito nastupa kasnije, nekoliko sati do nekoliko dana nakon rođenja.
English: • minimal to no desire or need to abuse opioids
Croatian: • minimalna ili nikakva želja ili potreba za zlouporabom opioida
English: Location of implant: (upper arm: left / right)
Croatian: Mjesto implantata: (nadlaktica: lijeva / desna)